240 related articles for article (PubMed ID: 30150753)
1. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma.
Liu T; Ma W; Xu H; Huang M; Zhang D; He Z; Zhang L; Brem S; O'Rourke DM; Gong Y; Mou Y; Zhang Z; Fan Y
Nat Commun; 2018 Aug; 9(1):3439. PubMed ID: 30150753
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
3. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma.
Huang M; Liu T; Ma P; Mitteer RA; Zhang Z; Kim HJ; Yeo E; Zhang D; Cai P; Li C; Zhang L; Zhao B; Roccograndi L; O'Rourke DM; Dahmane N; Gong Y; Koumenis C; Fan Y
J Clin Invest; 2016 May; 126(5):1801-14. PubMed ID: 27043280
[TBL] [Abstract][Full Text] [Related]
4. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1α in human glioblastoma.
Clara CA; Marie SK; de Almeida JR; Wakamatsu A; Oba-Shinjo SM; Uno M; Neville M; Rosemberg S
Neuropathology; 2014 Aug; 34(4):343-52. PubMed ID: 24612214
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
7. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma.
Huang M; Zhang D; Wu JY; Xing K; Yeo E; Li C; Zhang L; Holland E; Yao L; Qin L; Binder ZA; O'Rourke DM; Brem S; Koumenis C; Gong Y; Fan Y
Sci Transl Med; 2020 Feb; 12(532):. PubMed ID: 32102932
[TBL] [Abstract][Full Text] [Related]
8. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies.
Faes S; Uldry E; Planche A; Santoro T; Pythoud C; Demartines N; Dormond O
Oncotarget; 2016 Dec; 7(52):86026-86038. PubMed ID: 27852069
[TBL] [Abstract][Full Text] [Related]
9. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
[TBL] [Abstract][Full Text] [Related]
10. E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.
Engelmann D; Mayoli-Nüssle D; Mayrhofer C; Fürst K; Alla V; Stoll A; Spitschak A; Abshagen K; Vollmar B; Ran S; Pützer BM
J Mol Cell Biol; 2013 Dec; 5(6):391-403. PubMed ID: 24014887
[TBL] [Abstract][Full Text] [Related]
11. PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment.
di Tomaso E; London N; Fuja D; Logie J; Tyrrell JA; Kamoun W; Munn LL; Jain RK
PLoS One; 2009; 4(4):e5123. PubMed ID: 19352490
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
Campanella R; Guarnaccia L; Cordiglieri C; Trombetta E; Caroli M; Carrabba G; La Verde N; Rampini P; Gaudino C; Costa A; Luzzi S; Mantovani G; Locatelli M; Riboni L; Navone SE; Marfia G
Cells; 2020 Jan; 9(2):. PubMed ID: 31991805
[No Abstract] [Full Text] [Related]
13. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
14. Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production.
Gao Y; Zhang Y; Yao Y; Guan X; Liu Y; Qi X; Wang Y; Liu C; Zhang Y; Gao H; Nair V; Wang X; Gao Y
Oncotarget; 2016 Dec; 7(49):80275-80287. PubMed ID: 27852059
[TBL] [Abstract][Full Text] [Related]
15. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
16. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.
D'Haene N; Koopmansch C; Van Eycke YR; Hulet F; Allard J; Bouri S; Rorive S; Remmelink M; Decaestecker C; Maris C; Salmon I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423986
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
19. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
Bäckman U; Christofferson R
Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis.
Kim DG; Jin Y; Jin J; Yang H; Joo KM; Lee WS; Shim SR; Kim SW; Yoo J; Lee SH; Yoo JS; Nam DH
MAbs; 2015; 7(6):1195-204. PubMed ID: 26325365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
